The Healthtech Podcast

This week, James is joined by Graeme Cox, cofounder and CEO of emteq labs. Graeme has led multiple startup companies from initiation to exit, acting both as CEO and CTO with a 25-year track record in AI, software development, client engagement, problem solving and organisational development. His latest company, emteq labs, uses VR, multiple biometrics and machine learning to quantify human emotion. Their integrated system is the most ecologically valid and user-friendly solution on the market and by allowing researchers to harness more accurate data, they enable better research into how humans experience emotions. Listen to the Emotion Lab podcast: https://podcasts.apple.com/gb/podcast/emotion-lab/id1527627404 Get in touch with Graeme or emteq: https://emteqlabs.com/ | https://www.linkedin.com/in/graemercox/ Get in touch with James: www.jamessomauroo.com | www.somx.co.uk

This week's Sunday Session features some bonus content from a conversation between James and Amer Fasihi, cofounder and CEO of healthtech company, Kraydel. The full episode will be out in a couple of weeks, but you'll hear a chat between James and Amer from before they officially started recording the episode. They chat about identity and how it changes as you move careers and companies, the opportunity that comes with first-mover-advantage and entrepreneurs' self confessed affinity to high-risk scenarios. Get in touch: www.jamessomauroo.com | www.somx.co.uk

Lord Victor Adebowale is an influential and high profile healthtech leader who combines commercial acumen with a commitment to social responsibility and personal values. He is the founder and chair of healthtech company Visionable and was previously Chief Executive of the social care enterprise Turning Point. Lord Adebowale was one of the first to become a People's Peer and was appointed a Commander of the Order of the British Empire (CBE) in the 2000 New Year Honours for services to the New Deal, the unemployed, and homeless young people. In 2009 he was listed as one of the 25 most influential people in housing policy over the past 25 years by the housing professionals magazine Inside Housing and was reckoned by the Health Service Journal to be the 97th most influential person in the English NHS in 2015. Get in touch: www.jamessomauroo.com | www.somx.co.uk 

For this week's Sunday Session, James is joined by Dr Mala Mawkin, award winning doctor, speaker and writer. Mala is featured on Forbes 30 Under 30, Vogue 10 Rising Female Stars and UK Women of the Future Awards Finalist. She is the Host of the Digital Health Podcast for The Royal Society of Medicine Digital Health Council and is an advocate for women in science & medicine. She is now working at UK healthtech startup, Cellen.   https://www.malamawkin.com/ | https://www.linkedin.com/in/malamawkin/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

Dr Mark Jenkins is Co-Founder and Medical Director at Oviva UK Ltd, a company digitising behaviour change therapy for lifestyle conditions such as Type 2 diabetes and obesity. Mark trained as a doctor at Guy’s & St Thomas Hospitals in London, where he also completed an academic foundation programme specialising in nephrology and then worked at the Boston Consulting Group. Mark is Oviva's UK Managing Director and leads Oviva’s research strategy and partnerships with the NHS. Get in touch: www.somx.co.uk | www.jamessomauroo.com 

For this week's Sunday Session, James looks back on his first year as a doctor and gives a few tips and anecdotes for those looking to innovate, be that through QI projects, as an interpreneur or as an entrepreneur. Whether you're fixing a printer or overhaul an entire system, there is no project too big or too small to either learn from or make impact with. Empathy and understanding of how everyone in the hospital works is crucial and James talks about the value of spending time shadowing and learning from the management side of the hospital to help you make impact. Get in touch: www.jamessomauroo.com | www.somx.co.uk

Robyn Symon is a two-time Emmy award-winning former PBS producer  specializing in documentaries and television series. A former TV news reporter, Robyn has written and produced hundreds of hours of television programming for various networks including PBS, NBC, Discovery, CNBC, HGTV Reelz Channel including the PBS series "Voices of Vision," hosted by NPR's Scott Simon focusing on the work of non-profit organizations around the world and “Florida!" for The Travel Channel.  Recently Robyn produced and directed five television specials for the Reelz Channel on Michael Jackson, Robin Williams and the opioid epedimic in Hollywood (“Fatal Addiction”).  In addition to two Suncoast Emmys, Robyn has been honored with three national Telly awards among others. Her latest film, Do No Harm premiered at the Cleveland International Film Festival: Jumping off hospital rooftops, hanging themselves in janitorial closets, overdosing on drugs—they’re A students and their suicides are often like well-planned school projects. Doctors are our healers, yet they have the highest rate of suicide among any profession. Medical students and families of physicians touched by suicide come out of the shadows to expose this silent epidemic and the truth about a sick healthcare system that not only drives our brilliant young doctors to take their own lives but puts patients lives at risk too. https://www.donoharmfilm.com/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

It's a 241 on GE healthcare this week - Rob Walton, President and CEO across 13 markets is back to give us his top tips for healthtech entrepreneurs. James also talks about perfection being the enemy of progress and how he's had to combat it in the last week!  https://www.linkedin.com/in/rob-walton-511555/ | https://www.gehealthcare.co.uk/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Rob Walton, the president and CEO of GE Healthcare's businesses in 13 markets across Southeast Asia, Korea, Australia and New Zealand. He took on the role in June 2019 and is responsible for leading all the business activities for GE healthcare in the region. https://www.linkedin.com/in/rob-walton-511555/ | https://www.gehealthcare.co.uk/ Get in touch:  www.jamessomauroo.com | www.somx.co.uk

Tomer is a Partner & CFO at aMoon, where he leads mid-late stage investments in healthtech companies. Tomer joined aMoon in early 2018 and led several investments including $30M Series C round in Zebra Medical Vision and $55M Series D round in Seer. He is also a board member in PharmaTwoB and Mapi. With 15 years of US capital markets experience, Tomer spearheads aMoon’s Bridge to Wall Street, where he manages the fund’s relationships with major investment banks, equity research analysts and investment funds. Prior to joining aMoon, Tomer was the CFO & COO of Alcobra, a NASDAQ-listed development-stage biotech company, where he led successful public equity offerings from leading US healthcare funds. Prior to joining Alcobra, he was an Executive Director in J.P. Morgan’s Investment Banking Division in New York, where he played a leading role in numerous capital market and mergers and acquisitions transactions. In this capacity, he advised senior management and boards of directors of J.P. Morgan's key U.S. clients, including several S&P 500 healthcare firms. Prior to joining J.P. Morgan, Tomer worked in Citigroup's Investment Bank in New York. From 2000 to 2003, he served as an economist in the Financial Advisory Unit to the Chief of Staff of the Israel Defense Forces. Tomer holds a Ph.D. in Finance and Economics (with Distinction) from Columbia Business School and has published a number of corporate finance articles in leading academic and practitioner journals. He also holds an M.Sc. in Finance and Accounting (Magna Cum Laude) and a B.A. in Economics and Management (Magna Cum Laude), both from Tel-Aviv University. https://www.linkedin.com/in/tomerberkovitz/ | https://www.amoon.fund/ Get in touch: www.jamessomauroo.com | www.somx.co.uk